{
  "ptid_time": "057_S_5199_2013-05-31",
  "img_path": "/data/qiuhui/data/adni/images/057_S_5199/2013-05-31/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,290 mm³, 62.5% above the reference mean. With a Z-score of 1.56 (94.1th percentile), this represents moderate enlargement; hippocampal volume measures 6,923 mm³, 9.9% below the reference mean. With a Z-score of -1.11 (13.3th percentile), this represents mild atrophy; whole brain volume measures 974,542 mm³, 5.3% below the reference mean. With a Z-score of -0.66 (25.4th percentile), this represents normal volume ; entorhinal cortex volume measures 3,292 mm³, 15.4% below the reference mean. With a Z-score of -1.20 (11.6th percentile), this represents mild atrophy; fusiform gyrus volume measures 19,260 mm³, 5.8% above the reference mean. With a Z-score of 0.65 (74.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,225 mm³, 16.1% below the reference mean. With a Z-score of -1.43 (7.7th percentile), this represents mild atrophy. ",
  "text_data": "Age is 66.8 years. Gender is Female. Education: 15 years. Handedness: Left. Race: Black or African American. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 28.0. MoCA: 22.0. Logical Memory: 11.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.64 SUVR (profound elevated); Amyloid beta: 467.10 pg/mL (mild reduced); Total tau: 155.10 pg/mL (mild reduced); Phosphorylated tau: 15.72 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate ventricular enlargement and mild atrophy in the hippocampus, entorhinal cortex, and middle temporal gyrus—regions critical for memory and cognition. Combined with mildly reduced Aβ (amyloid) and profoundly elevated AV45 (amyloid PET), this suggests early neurodegenerative changes. However, the MMSE (28/30) is near-normal, while the MoCA (22/30) indicates mild cognitive impairment (MCI), likely amnestic given hippocampal involvement.  \n\n**Diagnosis:** **MCI (Mild Cognitive Impairment)**  \n**Confidence:** **Medium** (Biomarkers and imaging support neurodegeneration, but high MMSE and lack of functional decline preclude a dementia diagnosis. APOE4-negative status and normal P-tau reduce certainty.)  \n\n*Note: Follow-up clinical correlation (e.g., neuropsychological testing) and longitudinal monitoring for progression to dementia (likely Alzheimer’s given amyloid burden) are recommended.*",
  "timestamp": "2025-07-26T08:14:51.978768"
}